Related Experiment Video
Updated: Sep 26, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
[Invasive candidosis in intensive care unit patients]
1Neurologisches Rehabilitationszentrum Greifswald, Karl-Liebknecht-Ring 26A, D-17491 Greifswald, Deutschland. a.gloeckner@nrz-greifswald.de
Abstract:
The incidence of invasive candidosis is increasing worldwide and the mortality is high. In the intensive care unit diagnostic measurements, correct evaluation of the findings and the right indication for antifungal treatment remain problematic. So determination of potential risk factors is very important. The therapeutic use of antifungal drugs is often limited by important disadvantages like inadequate spectrum, application form or side effects. New antifungals give hope for the near future.
Insights
Invasive candidosis is rising globally with high mortality. Identifying risk factors is crucial for effective antifungal treatment in intensive care units, where current diagnostics and therapies face challenges.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Context:
- Rising global incidence of invasive candidosis.
- High mortality rates associated with invasive fungal infections.
- Challenges in diagnosing and treating invasive candidosis in intensive care units (ICUs).
Purpose:
- To highlight the importance of identifying risk factors for invasive candidosis.
- To address the difficulties in diagnostic evaluation and antifungal treatment indications in ICUs.
- To discuss limitations of current antifungal therapies and the potential of new agents.
Summary:
- Invasive candidosis is an increasing worldwide threat with significant mortality.
- Accurate diagnosis and appropriate antifungal treatment in ICUs remain challenging.
- Development of new antifungals is essential to overcome limitations of existing therapies.
Impact:
- Improved understanding of risk factors may lead to earlier detection and intervention.
- Advances in diagnostics and treatment strategies could reduce mortality from invasive candidosis.
- New antifungal agents promise enhanced efficacy and safety profiles for patient care.
More Related Videos
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis IV: Nursing Management

